40 reports

  • Erythropoietin: An overview
  • Second-generation erythropoietin formulation

About Erythropoietin Drugs The global erythropoietin drugs market is expected to witness a slow growth rate during the forecast period. In 2016, EMEA dominated the market, followed by the Americas and APAC. India and China are the leading countries in the market in APAC. While Sandoz and Dr. Reddy's Laboratories dominate the...

  • Erythropoietin
  • World
  • Forecast
  • Amgen Inc.
  • Kyowa Hakko Kirin Co., Ltd.

Global Erythropoietin Market Forecast 2017-2027 ##.

  • Biopharmaceutical
  • Erythropoietin
  • World
  • Market Size
  • Global erythropoietin drugs market
  • ERYTHROPOIETIN DRUGS MARKET IN JAPAN 2014-2019 ($ MILLIONS)

About erythropoietin Erythropoietin (EPO), also referred to as hematopoietin or hemopoietin, is a glycoprotein that is responsible for the production of erythrocytes in the body. In the fetal stage, this protein is produced in the liver. However, in adulthood it is produced in the kidneys. During anemic conditions, the body produces an...

  • Erythropoietin
  • Japan
  • Chugai Pharmaceutical Co., Ltd.
  • Kissei Pharmaceutical Co., Ltd.
  • Kyowa Hakko Kirin Co., Ltd.

## Global Erythropoietin Drug Market Outlook, By Region (2014-2022) ($MN) Table ## Global Erythropoietin Drug Market Outlook, By Product (2014-2022) ($MN) Table ## Global Erythropoietin Drug Market Outlook, By Biosimilars (2014-2022) ($MN) Table ## Global

  • Erythropoietin
  • APAC
  • Europe
  • World
  • Market Size

EPO Biosimilars - The Future of Erythropoietin Market ##.

  • Biopharmaceutical
  • Erythropoietin
  • World
  • Market Size

In addition, major players of the erythropoietin drug, along with their upcoming and anticipated erythropoietin-related products are analyzed to demonstrate how these advances might impact global erythropoietin drug market.

  • Biopharmaceutical
  • Erythropoietin
  • World
  • Forecast

European Erythropoietin Market Outlook 2022 ##.

  • Biopharmaceutical
  • Erythropoietin
  • Europe
  • Market Size

Reddy’s Laboratories Ltd. ##. ##. ##. ## Company overview ##. ##. ##. ## Financial performance ##. ##. ##. ## Product benchmarking ##. ##. ##. ## Strategic initiatives List of Tables TABLE ## Country share estimation TABLE ## North America erythropoietin drugs market, by country, 2014 - 2025 (USD Million) T

  • Biopharmaceutical
  • Erythropoietin
  • United States
  • Forecast

Global Erythropoietin Market Outlook 2020 ##.

  • Biopharmaceutical
  • Erythropoietin
  • World
  • Market Size
  • Erythropoietin: An overview
  • Global erythropoietin market

About the Recombinant Human Erythropoietin (rhEPO) Market in China Erythropoietin (EPO), also referred to as hematopoietin or hemopoietin, is a glycoprotein responsible for producing erythrocytes in the body. In the fetal stage, this protein is produced in the liver; it is secreted by the kidneys in adulthood. During anemic conditions,...

  • Erythropoietin
  • China
  • Market Size
  • 3SBio Inc.
  • Kyowa Hakko Kirin Co., Ltd.
  • 53.52% OF THE MARKET SHARE COMES FROM GLOBAL MABS MARKET

About Protein Therapeutics Therapeutic proteins are used to effectively treat a wide array of diseases such as protein deficiency diseases; chronic diseases such as cancer, rheumatoid arthritis (RA), ankylosing spondylitis, diabetes; infections such as human immunodeficiency virus (HIV), hepatitis A, hepatitis B, and hepatitis C; and other...

  • Erythropoietin
  • AbbVie Inc.
  • Amgen Inc.
  • Merck & Co., Inc.
  • Novo Nordisk Group
  • II. BUSINESS ENVIRONMENT
  • IV

The auto exports exceeded over ## million each year.

  • Biotechnology
  • Erythropoietin
  • China
  • Demand
  • Supply

(USA) ##.

  • Biopharmaceutical
  • Erythropoietin
  • Pathology
  • World
  • Market Shares

(USA) ##.

  • Erythropoietin
  • China
  • United States
  • World
  • Market Shares

(Israel) ##.

  • Biopharmaceutical
  • Erythropoietin
  • Pathology
  • World
  • Market Shares

The drug consists of recombinant human erythropoietin and targets the erythropoietin receptor, initiating the same pathway as native erythropoietin and triggering increased blood production in bone marrow (EMC, 2017).

  • Biopharmaceutical
  • Erythropoietin
  • European Union
  • Japan
  • Supply

The drug consists of recombinant human erythropoietin and targets the erythropoietin receptor, initiating the same pathway as native erythropoietin and triggering increased blood production in bone marrow (EMC, 2017).

  • Biopharmaceutical
  • Erythropoietin
  • European Union
  • Japan
  • Supply

(France) ##.

  • Erythropoietin
  • Pharmaceutical
  • United States
  • World
  • Market Shares

Drug Analysis: Mircera

9091 10000 7727

Mircera is administered by intravenous or subcutaneous injection, and targets the erythropoietin receptor, initiating the same pathway as native erythropoietin and triggering increased blood production in bone marrow.

  • Erythropoietin
  • European Union
  • Japan
  • United States
  • Supply

Drug Overview: Mircera

9091 10000 7727

& nbsp; Mircera is administered by intravenous or subcutaneous injection, and targets the erythropoietin receptor, initiating the same pathway as native erythropoietin and triggering increased blood production in bone marrow.

  • Erythropoietin
  • European Union
  • Japan
  • United States
  • Supply
  • 1.1 ERYTHROPOIETIN
  • ERYTHROPOIETIN RESPONSE TO HYPOXIA

Erythropoietin is a substance produced by the kidney that leads to the formation of red blood cells in the bone marrow. It is a glycoprotein hormone which regulates erythropoiesis (Red Blood Cell production). For erythrocyte precursors present in the bone marrow, EPO acts as a cytokine. Commonly referred to as hematopoietin or hemopoietin,...

  • Erythropoietin
  • World
  • Forecast
  • Market Size
  • Roche Group

Drug Overview: Aranesp

9091 10000 7727

The drug targets the erythropoietin receptor, initiating the same pathway as native erythropoietin, and triggering increased blood production in bone marrow.

  • Erythropoietin
  • European Union
  • Japan
  • United States
  • Supply

Drug Analysis: Aranesp

9091 10000 7727

The drug targets the erythropoietin receptor, initiating the same pathway as native erythropoietin, and triggering increased blood production in bone marrow.

  • Erythropoietin
  • European Union
  • Japan
  • United States
  • Supply

(USA) ##.

  • Erythropoietin
  • China
  • United States
  • Market Competition
  • Market Shares
  • ERYTHROPOIETIN - DRUG PROFILE
  • PHEP-01 - DRUG PROFILE

Chemotherapy Induced Anemia - Pipeline Review, H1 2018 Summary Global Markets Direct’s latest Pharmaceutical and Healthcare disease pipeline guide Chemotherapy Induced Anemia - Pipeline Review, H1 2018, provides an overview of the Chemotherapy Induced Anemia (Toxicology) pipeline landscape. Chemotherapy-induced...

  • Chemotherapy
  • Erythropoietin
  • Japan
  • United States
  • World
  • PEGYLATED ERYTHROPOIETIN - DRUG PROFILE
  • PHEP-01 - DRUG PROFILE

Chemotherapy Induced Anemia - Pipeline Review, H2 2017 Summary Global Markets Direct’s latest Pharmaceutical and Healthcare disease pipeline guide Chemotherapy Induced Anemia - Pipeline Review, H2 2017, provides an overview of the Chemotherapy Induced Anemia (Toxicology) pipeline landscape. Chemotherapy-induced...

  • Blood Disease
  • Chemotherapy
  • Erythropoietin
  • Oncology
  • Tolero Pharmaceuticals, Inc.
  • ERYTHROPOIETIN - DRUG PROFILE
  • R&D Progress

Anemia in Chronic Kidney Disease (Renal Anemia) - Pipeline Review, H2 2017 Summary Global Markets Direct’s latest Pharmaceutical and Healthcare disease pipeline guide Anemia in Chronic Kidney Disease (Renal Anemia) - Pipeline Review, H2 2017, provides an overview of the Anemia in Chronic Kidney Disease...

  • Chronic Disease
  • Erythropoietin
  • Japan
  • United States
  • Product Initiative
  • ERYTHROPOIETIN - DRUG PROFILE
  • PEGYLATED ERYTHROPOIETIN - DRUG PROFILE

Anemia in Chronic Kidney Disease (Renal Anemia) - Pipeline Review, H1 2018 Summary Global Markets Direct’s latest Pharmaceutical and Healthcare disease pipeline guide Anemia in Chronic Kidney Disease (Renal Anemia) - Pipeline Review, H1 2018, provides an overview of the Anemia in Chronic Kidney Disease...

  • Chronic Disease
  • Erythropoietin
  • Japan
  • United States
  • Product Initiative

MARKET ##.

  • Biological Therapy
  • Erythropoietin
  • APAC
  • World
  • Company Sales
  • 8.4 ERYTHROPOIETIN (EPO)
  • PEGYLATED PROTEINS MARKET SIZE FOR ERYTHROPOIETIN, BY REGION, 2014-2021 (USD MILLION)

The global PEGylated proteins market is expected to USD 1,137.8 million by 2021 from USD 690.6 million in 2016, at a CAGR of 10.5% between 2016 and 2021. The growth of this market is mainly driven by increase in R&D spending of pharmaceutical & biotechnology companies, growth in biologics sector, high prevalence of lifestyle disease, and increase...

  • Erythropoietin
  • North America
  • United States
  • Market Size
  • JenKem Technology Co., Ltd